European Journal of Nuclear Medicine

, Volume 23, Issue 4, pp 459–465

The uptake mechanisms of inflammation-and infection-localizing agents

  • Wim J. G. Oyen
  • Otto C. Boerman
  • Conny J. van der Laken
  • Roland A. M. J. Claessens
  • Jos W. M. van der Meer
  • Frans H. M. Corstens
Review Article

DOI: 10.1007/BF01247377

Cite this article as:
Oyen, W.J.G., Boerman, O.C., van der Laken, C.J. et al. Eur J Nucl Med (1996) 23: 459. doi:10.1007/BF01247377

Abstract

Over the past 30 years, a wide variety of radiopharmaceuticals have been proposed for the scintigraphic detection of inflammatory and infectious disease. All radiopharmaceuticals yield a functional image of a process placed somewhere in the cascade of reactions in inflammation, this being the common pathway of response to tissue injury. This paper discusses relevant aspects of the biodistribution, in vivo kinetics and mechanisms of uptake of both clinically used and experimental radiopharmaceuticals that have been proposed for the scintigraphic detection of focal inflammation and infection.

Key words

ScintigraphyLeucocytesLiposomesNanocolloidImmunoglobulinsInfectionInflammation

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Wim J. G. Oyen
    • 1
  • Otto C. Boerman
    • 1
  • Conny J. van der Laken
    • 1
  • Roland A. M. J. Claessens
    • 1
  • Jos W. M. van der Meer
    • 2
  • Frans H. M. Corstens
    • 1
  1. 1.Department of Nuclear MedicineUniversity Hospital NijmegenNijmegenThe Netherlands
  2. 2.Department of Internal MedicineUniversity Hospital NijmegenNijmegenThe NetherlandsThe Netherlands